Effect of Dietary Lipid-Lowering Drugs upon Plasma Lipids and Egg Yolk Cholesterol Levels of Laying Hens

详细信息    查看全文

• 作者：Agnes V. Mori ; Cassio X. Mendonç ; a ; Jr. ; and Cristiane O. F. Santos
• 刊名：Journal of Agricultural and Food Chemistry
• 出版年：1999
• 出版时间：November 1999
• 年：1999
• 卷：47
• 期：11
• 页码：4731 - 4735
• 全文大小：42K
• 年卷期：v.47,no.11(November 1999)
• ISSN：1520-5118

文摘

To evaluate the effect of lipid-lowering agents upon egg quality, reproductive performance, plasmalipids, and egg yolk cholesterol levels, 30-week-old Shaver laying hens were fed a basal diet(commercial ration) supplemented with 0.1% probucol (PROB), 0.025% gemfibrozil (GEMF), orlovastatin at 0.0005% (LOV1), 0.001% (LOV2), or 0.0015% (LOV3) for a 12-week experimental period.It was observed that the supplementation of the drugs did not impair albumen and shell quality.Hen performance was not adversely affected. The depression in triglyceride concentrationsapproached statistical significance only in LOV2 (38.5%), and total cholesterol was significantlydepressed in LOV2 (36.0%), LOV3 (36.8%), PROB (29.6%), and GEMF (30.4%) treatments. Eggcholesterol content, expressed per gram of yolk, was significant lowered in LOV1 (7.5%) and LOV3(12.7%).Keywords: Cholesterol; egg yolk; lipid-lowering drugs; lipids; hens